Health Literacy in Clinical Research: Practice and Impact: Proceedings of a Workshop (2020)
Chapter: Appendix A: Workshop Agenda
Appendix A
Workshop Agenda
THURSDAY, APRIL 11, 2019
| 7:45–8:15 AM | REGISTRATION |
| 8:30–8:40 AM | WELCOME AND WORKSHOP OVERVIEW |
| Lawrence G. Smith, Roundtable on Health Literacy | |
| 8:40–10:00 AM | SESSION 1: HEALTH LITERACY IS AN ETHICAL IMPERATIVE IN CLINICAL TRIALS |
| 8:40–9:00 AM | Keynote 1: Why Health Literacy Matters |
| Barbara E. Bierer, Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard | |
| 9:00–9:20 AM | Keynote 2: How Health Literacy Helps Patients Make Decisions |
| Deborah Collyar, Patient Advocates in Research | |
| 9:20–10:00 AM | Moderated Discussion |
| Moderator: Larry G. Smith | |
| 10:00–10:15 AM | BREAK |
| 10:15 AM–12:15 PM | SESSION 2: EMBEDDING HEALTH LITERACY INTO CLINICAL TRIALS FROM THE BEGINNING OF THE PROCESS TO IMPROVE RECRUITMENT AND RETENTION |
| 10:15–11:30 AM | Presentations and Panelist Discussion |
|
Ebony Boulware, Duke University School of Medicine |
|
|
Catina O’Leary, Health Literacy Media |
|
|
Alicia Staley, Medidata Solutions |
|
|
Christopher R. Trudeau, University of Arkansas Medical School and Bowen School of Law, University of Arkansas at Little Rock |
|
|
Moderator: Annlouise R. Assaf, Pfizer Worldwide Medical and Safety |
|
| 11:30 AM–12:15 PM | Discussion |
| 12:15–1:15 PM | BREAK |
| 1:15–2:45 PM | SESSION 3: EXPERIENCES IN IMPLEMENTING HEALTH LITERACY IN CLINICAL TRIALS |
| 1:15–2:00 PM | Presentations |
|
Connie Arnold, Louisiana State University Health Sciences Center |
|
Lauren McCormack, Public Health Research, RTI International |
|
|
Saira Z. Sheikh, University of North Carolina School of Medicine |
|
| 2:00–2:45 PM | Moderated Discussion |
|
Moderator: Phyllis J. Pettit Nassi, Huntsman Cancer Institute |
|
| 2:45–3:00 PM | BREAK |
| 3:00–4:30 PM | SESSION 4: WHAT DOES THE FUTURE HOLD FOR DESIGNING CLINICAL TRIALS USING HEALTH LITERACY BEST PRACTICES? |
| 3:00–4:00 PM | Moderated Panel Discussion |
|
Emma Andrews, Pfizer Biopharmaceuticals Group |
|
|
Monika Mitra, Brandeis University |
|
|
Jovonni R. Spinner, Office of Minority Health, U.S. Food and Drug Administration |
|
|
Rebecca J. Williams, ClinicalTrials.gov |
|
|
Moderator: Terry C. Davis, Louisiana State University Health Sciences Center |
|
| 4:00–4:30 PM | Discussion |
| 4:30–4:50 PM | SESSION 5: WORKSHOP HIGHLIGHTS |
|
Patty Spears, University of North Carolina Lineberger Comprehensive Cancer Center |
|
|
Consuelo H. Wilkins, Vanderbilt University Medical Center |
|
| 4:50–5:30 PM | SESSION 6: ROUNDTABLE REFLECTIONS ON THE DAY |
|
Moderator: Lawrence G. Smith |
|
| 5:30 PM | ADJOURN |
This page intentionally left blank.
